✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Jiangsu Hengrui Pharmaceuticals Co Ltd

Common Name
Jiangsu Hengrui Pharmaceuticals
Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
20,238
Ticker
600276
Exchange
SHANGHAI STOCK EXCHANGE
Description
Jiangsu Hengrui Pharmaceuticals Co., Ltd. is a prominent player in the biopharmaceutical industry, focused on the research, development, manufacturing, and marketing of a comprehensive range of medica...

Jiangsu Hengrui Pharmaceuticals's Waste Data Preview

In 2023, Jiangsu Hengrui Pharmaceuticals conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards.The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.

Metric (tonnes)2023202220212020 - 2017
Total Waste Generated
0000000
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
a
0000000
Total Waste Recovered
Copy/Paste is a PRO feature.
0000000
Copy/Paste is a PRO feature.
0000000
Total Hazardous Waste Generated
0000000
0000000
Copy/Paste is a PRO feature.
a
0000000
Non-Hazardous Waste Disposed
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
0000000
0000000
Limited Data Preview
You are viewing a limited preview of Jiangsu Hengrui Pharmaceuticals’s Waste Management dataset. The full dataset, available for download, includes total waste generated, broken down by hazardous and non-hazardous streams, along with reported recovery and disposal figures with historical coverage back to 2021.
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Jiangsu Hengrui Pharmaceuticals’s Waste Management Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Jiangsu Hengrui Pharmaceuticals’s data sources below and access millions more through our Disclosure Search.

a. Jiangsu Hengrui Pharmaceuticals's ESG Report 2023

Insights into Jiangsu Hengrui Pharmaceuticals’s Generation of Hazardous and Non-Hazardous Waste

In 2023, Jiangsu Hengrui Pharmaceuticals generated a total of 18,931 metric tonnes of waste.a

Of this amount, 97.69% of Jiangsu Hengrui Pharmaceuticals's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment.2.31% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.a

Jiangsu Hengrui Pharmaceuticals’s Hazardous vs Non-Hazardous Waste Over Time

20212022202305 k10 k15 k20 ktonnes
  • Total Non-Hazardous Waste Generated
  • Total Hazardous Waste Generated

How Jiangsu Hengrui Pharmaceuticals reduced the environmental impact of its waste?

Since 2021, Jiangsu Hengrui Pharmaceuticals's total waste generation increased by 29.42%, including a 30.96% rise in 2023, reflecting a persistent upward trend that could be linked to operational growth, inefficient material use, or limited investment in waste prevention systems.a

Over the same period, Jiangsu Hengrui Pharmaceuticals's hazardous waste share remained stable both over the long term and in 2023, reflecting consistent but static performance in managing hazardous materials.a

Overall, Jiangsu Hengrui Pharmaceuticals is producing more waste without a change in hazardousness, implying that operational growth is not being accompanied by stronger safeguards against environmental and human health risks.a

Want Full Access to Jiangsu Hengrui Pharmaceuticals's Waste Management Dataset?
Start 30-Day Free Trial